Abstract
Sufficient progress has occurred in identifying, characterizing, and surgically repairing physiologically important congenital cardiac defects (which occur at the rate of 20,000/yr in the United States) that 85% of these infants can now expect to survive to adulthood. Since only the most severe structural malformations thwart current management schemes, prevention and early in utero detection are the remaining strategies to further reduce the impact of heart malformation on the health of infants and children; however, any prevention approach would depend largely on knowing the percentage of congenital heart defects that are genetic. For example, if the vast majority of congenital heart anomalies are due to intrauterine insults (infectious agents, toxins, mechanical stress, and so on) to the embryo during the first 30 days of gestation, then a prevention strategy would be ineffective; since most pregnancies are already monitored by ultrasound at least once for accurate dating, perhaps adding a “cardiac surveillance” portion to the imaging protocol would suffice to increase the chance of prenatal identification. However, evidence has begun to accumulate for the hypothesis that the majority of congenital heart malformations are due to gene alterations. Therefore, the scientific challenge of the next several decades will be to unravel the sequence of molecular decisions that result in the construction of the heart and blood vessels from the first embryonic tissue layers. Although more than 50 genes have already been reported to be involved in cardiovascular morphogenesis (Table 12-1), the way they function to form the heart and great vessels correctly (in space and time) remains obscure. Both forward and reverse genetic approaches are being tried, and a variety of organisms are being scrutinized since the underlying mechanisms of patterning appear to be widely shared among vertebrates. Murine cardiac development is difficult to study in vivo without new imaging techniques because of the relatively inaccessible embryo. Furthermore, a systematic screen of the mouse genome for embryonic lethal mutations affecting organogenesis is impractical. Other vertebrates such as the chick Gallus gallus and the African clawed frog Xenopus laevis have long generation times. The teleost fish Danio (formerly Brachydanio) rerio (zebrafish) has emerged as a model system because of its prolific egg production, rapid (90-d) generation time, optically transparent embryo, and extremely rapid heart development (48 h). Despite the advantages of the zebrafish system for mutational analysis, there are some aspects of cardiovascular construction, namely septation and pulmonary artery formation, that must be studied in higher vertebrates.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Selected References
Budarf M, Collins J, Gong W, et al. Cloning a balanced translocation associated with diGeorge syndrome and identification of a disrupted candidate gene. Nat Genet 1995; 10: 269–277.
Chen J-N, Haffter P, Odenthal J, et al. Mutations affecting the cardiovascular system and other internal organs in zebrafish. Development 1996; 123: 293–302.
Goldmuntz E, Emanuel BS. Genetic disorders of cardiac morphogenesis. The DiGeorge and Velocardiofacial syndromes. Circ Res 1997; 80: 437–443.
Harvey RP. NK-2 homeobox genes and heart development. Dev Biol 1996; 178: 203–216.
Keating M. Elastin and vascular disease. Trends Cardiovasc Med 1994; 4: 165–169.
Kimmel CB. Genetics and early development of zebrafish. Trends in Genetics 1989; 5: 283–288.
Kuo CT, Morrisey EE, Anandappa R, et al. GATA 4 transcription factor is required for ventral morphogenesis and heart tube formation. Genes Dev 1997; 11: 1048–1060.
Lee RY, Luo J, Evans RM, Giguere V, Surov HM. Compartment-selective sensitivity of cardiovascular morphogenetics to combinations of retinoic acid receptor gene mutations. Circ Res 1997; 80: 757–764.
Lin Q, Schwarz J, Bucana C, Olson EN. Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science 1997; 276: 1404–1407.
Molkentin JD, Lin Q, Duncan SA, Olson EN. Requirement of the transcription factor GATA4 for heart tube formation and ventral morpho-genesis. Genes Dev 1997; 11: 1061–1072.
Reaume AG, deSousa PA, Kulkarni S, et al. Cardiac malformation in neonatal mice lacking connexin 43. Science 1995; 267: 1831–1834.
Srivastava D, Thomas T, Lin Q, Kirby ML, Brown D, Olson EN. Regulation of cardiac mesodermal and neural crest development by the bHLH transcription factor dHAND. Nat Genet 1997; 16: 154–160.
Stainier DYS, Fouquet B, Chen J-N, et al. Mutations affecting the formation and function of the cardiovascular system in the zebrafish embryo. Development 1996; 123: 285–292.
Supp DM, Witte DP, Potter SS, Brueckner M. Mutation of an axonemal dynein affects left-right asymmetry in inversus viscerum mice. Nature 1997; 389: 963–966.
Tonissen KF, Drysdale TA, Lints TJ, Harvey RP, Krieg PA. XNkx-2.5, a Xenopus gene related to Nkx-2.5 and tinman: evidence for a conserved role in cardiac development. Dev Biol 1994; 162: 325–328.
Weinstein B, Stemple DL, Driever W, Fishman MC. Gridlock, a localized heritable vascular patterning defect in the zebrafish. Nature Medicine 1995; 1: 1143–1147.
Wu X, Golden K, Bodmer R. Heart development in Drosophila requires the segment polarity gene wingless. Dev Biol 1995; 169: 619–628.
Yang JT, Rayburn H, Hynes RO. Cell adhesion events mediated by a4 integrins are essential in placental and cardiac development. Development 1995; 121: 529–560.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Chin, A.J. (1998). Congenital Heart Disease. In: Jameson, J.L. (eds) Principles of Molecular Medicine. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-726-0_12
Download citation
DOI: https://doi.org/10.1007/978-1-59259-726-0_12
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4757-6272-3
Online ISBN: 978-1-59259-726-0
eBook Packages: Springer Book Archive